About

Privately held clinical stage pharmaceutical company located in Research Triangle Park, North Carolina. BHV develops drugs to treat metabolic disorders such as diabetes and obesity. The Company's lead development program is remogliflozin etabonate, a highly selective SGLT2 inhibitor for the treatment of type 2 diabetes.